Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker

Investigative Radiology

Volumn 49, Issue 10, 2014, Pages 647-652

  Li, Lu Ping ^a,b   Thacker, Jon ^c   Lu, Jing ^d   Franklin, Tammy ^b   Zhou, Ying ^e   Papadopoulou, Maria V ^f   Solomon, Richard ^f   Prasad, Pottumarthi V ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c Northwestern University   (United States)

^d Department of Obstetrics and Gynecology ^*  (United States)

^e Center for Clinical Research Informatics   (United States)

^f NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Acute kidney injury; BOLD MRI; Furosemide; Iodinated contrast; Kidney; NGAL; Nitric oxide; Oxygenation; Rats

Indexed keywords

ACETYLCYSTEINE; FUROSEMIDE; INDOMETACIN; IODIXANOL; IOHEXOL; IOXAGLIC ACID; N(G) NITROARGININE METHYL ESTER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACEBO; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CONTRAST MEDIUM; DIURETIC AGENT; IODOBENZOIC ACID DERIVATIVE; LIPOCALIN; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PROTEIN, RAT; ONCOPROTEIN; OXYGEN; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLD SIGNAL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; KIDNEY MEDULLA; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGENATION; PRIORITY JOURNAL; RAT; RENAL PROTECTION; URINALYSIS; ACUTE KIDNEY INJURY; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; KIDNEY; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; URINE;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ANIMALS; BIOMARKERS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DIURETICS; FREE RADICAL SCAVENGERS; FUROSEMIDE; IOHEXOL; IOXAGLIC ACID; KIDNEY; LIPOCALINS; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TRIIODOBENZOIC ACIDS;

EID: 84925825298     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000065     Document Type: Article

References (39)

1. Berlyne N, Berlyne GM. Acute renal failure following intravenous pyelography with hypaque. Acta Med Scand. 1962;171:39-41.
2. McDonald RJ, McDonald JS, Bida JP, et al. Intravenous contrast materialinduced nephropathy: causal or coincident phenomenon? Radiology. 2013;267:106-118.
3. Lacquaniti A, Buemi F, Lupica R, et al. Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? Radiology. 2013;267:86-93.
4. Brezis M, Rosen S. Hypoxia of the renal medullaVits implications for disease. N Engl J Med. 1995;332:647-655.
5. Agmon Y, Peleg H, Greenfeld Z, et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest. 1994;94:1069-1075.
6. Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol. 1999;34:685-691.
7. Liss P. Effects of contrast media on renal microcirculation and oxygen tension. An experimental study in the rat. Acta Radiol Suppl. 1997;409:1-29.
8. Palm F, Carlsson PO, Fasching A, et al. Effects of the contrast medium iopromide on renal hemodynamics and oxygen tension in the diabetic rat kidney. Adv Exp Med Biol. 2003;530:653-659.
9. Hofmann L, Simon-Zoula S, Nowak A, et al. BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int. 2006;70:144-150.
10. Prasad PV, Priatna A, Spokes K, et al. Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging. 2001;13:744-747.
11. Li LP, Franklin T, Du H, et al. Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose. J Magn Reson Imaging. 2012;36:1162-1167.
12. Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation. 2010;122:2451-2455.
13. Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284-294.
14. Ellis JH, Cohan RH. Prevention of contrast-induced nephropathy: an overview. Radiol Clin North Am. 2009;47:801-811.
15. Balemans CE, Reichert LJ, Van Schelven BI, et al. Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology. 2012;263:706-713.
16. Chousterman BG, Bouadma L, Moutereau S, et al. Prevention of contrastinduced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results. J Crit Care. 2013;28:701-709.
17. Epstein FH, Prasad P. Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int. 2000;57:2080-2083.
18. Heyman SN, Brezis M, Greenfeld Z, et al. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis. 1989;14:377-385.
19. Majumdar SR, Kjellstrand CM, Tymchak WJ, et al. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis. 2009;54:602-609.
20. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416-1420.
21. Li LP, Lu J, Zhou Y, et al. Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen leveldependent magnetic resonance imaging. Invest Radiol. 2014. [Epub ahead of print].
22. Lancelot E, Idee JM, Couturier V, et al. Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: a potential cause of nephrotoxicity. J Appl Toxicol. 1999;19:341-346.
23. Xin C, Yulong X, Yu C, et al. Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren Fail. 2008;30:904-913.
24. Peco-Antic A, Ivanisevic I, Vulicevic I, et al. Biomarkers of acute kidney injury in pediatric cardiac surgery. Clin Biochem. 2013;46:1244-1251.
25. De Greef KE, Ysebaert DK, Persy V, et al. ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF. Kidney Int. 2003;63:1697-1707.
26. Heyman SN, Brezis M, Reubinoff CA, et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest. 1988;82:401-412.
27. Burke TJ, Malhotra D, Shapiro JI. Effects of enhanced oxygen release from hemoglobin by RSR13 in an acute renal failure model. Kidney Int. 2001;60:1407-1414.
28. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron. 1992;62:413-415.
29. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97-104.
30. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994;45:259-265.
31. Evans RG, Smith JA, Wright C, et al. Urinary oxygen tension: a clinical window on the health of the renal medulla? Am J Physiol Regul Integr Comp Physiol. 2014;306:R45-R50.
32. Marenzi G, Ferrari C, Marana I, et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) trial. JACC Cardiovasc Interv. 2012;5:90-97.
33. Gloviczki ML, Glockner J, Gomez SI, et al. Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease. Invest Radiol. 2009;44:566-571.
34. Tumkur SM, Vu AT, Li LP, et al. Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using BOLD MRI. Kidney Int. 2006;70:139-143.
35. Sun Z, Fu Q, Cao L, et al. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS One. 2013;8:e55124.
36. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773-2782.
37. Briguori C, Colombo A, Violante A, et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J. 2004;25:206-211.
38. ∗ values. Invest Radiol. 2013;48:501-508.
39. Vaamonde CA, Bier RT, Papendick R, et al. Acute and chronic renal effects of radiocontrast in diabetic rats. Role of anesthesia and risk factors. Invest Radiol. 1989;24:206-218.